首页> Cancer immunology, immunotherapy : CII> Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab.

Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab.

导出 OA

翻译打印收藏纠错

第一作者： Mathilde,Bureau

第一单位： Medical Oncology Unit, Hôpital Laennec, CHU de Nantes, University Hospital of Nantes, Boulevard Professeur Jacques Monod, Saint Herblain, 44800, Nantes, France.

作者： Mathilde,Bureau ^[1] ; Thierry,Chatellier ^[2] ; Tanguy,Perennec ^[3] ; Thomas,Goronflot ^[4] ; Charlotte,Greilsamer ^[5] ; Anne-Laure,Chene ^[6] ; Raafet,Affi ^[1] ; Eric,Frampas ^[7] ; Jaafar,Bennouna ^[8] ; Elvire,Pons-Tostivint ^[9]

作者单位： Medical Oncology Unit, Hôpital Laennec, CHU de Nantes, University Hospital of Nantes, Boulevard Professeur Jacques Monod, Saint Herblain, 44800, Nantes, France. ^[1] Medical Oncology Unit, Clinique Mutualiste de l'Estuaire, Saint-Nazaire, France. ^[2] Department of Radiation Oncology, Institut de Cancerologie de L'Ouest, Saint-Herblain, France. ^[3] INSERM, University Hospital of Nantes, CIC 1413, PHU 11, Data Clinic, Nantes, France. ^[4] Medical Oncology Unit, Hospital of La Roche-sur-Yon, La Roche-sur-Yon, France. ^[5] Pneumology Unit, University Hospital of Nantes, Nantes, France. ^[6] Radiology Unit, University Hospital of Nantes, Nantes, France. ^[7] Medical Oncology Unit, Hôpital Laennec, CHU de Nantes, University Hospital of Nantes, Boulevard Professeur Jacques Monod, Saint Herblain, 44800, Nantes, France.;INSERM, CRCINA, Nantes, France. ^[8] Medical Oncology Unit, Hôpital Laennec, CHU de Nantes, University Hospital of Nantes, Boulevard Professeur Jacques Monod, Saint Herblain, 44800, Nantes, France. elvire.pons@chu-nantes.fr.;INSERM, CRCINA, Nantes, France. elvire.pons@chu-nantes.fr. ^[9]

关键词 Baseline tumour size Immune checkpoint inhibitor Non-small cell lung cancer Pembrolizumab

医学主题词癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);人类(Humans);肺肿瘤(Lung Neoplasms);预后(Prognosis);回顾性研究(Retrospective Studies)

DOI 10.1007/s00262-021-03108-x

PMID 34839373

发布时间 2024-04-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交